@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@
Group A-1 ‰»Šw\‘’@(Chemical Structure)  
œ ABS-sodium (Dodecylbensenesulfonic acid sodium salt)
@
12068-21-2I@ Industry@
AM Sal./ E.col. Max ( 5.0 mg/plate, }S9)   1)
CA CHL/IU cells Max ( 0.08 mg/ml, -S9), 6-18h   2)
1) Ishidate M.Jr.,et al.:@Natl. Inst. Hygien. Sci., 98, 1-19 (1980)
2) Ishidate M.Jr. & Odashima S.: Mutation Res., 48, 337 (1977)@
@@

œ Acenaphthene
iƒAƒZƒiƒtƒeƒ“j

@
83-32-9 @@Industry @ 154.22
AM Sal./E.col. Max ( 5.0 mg/plate, }S9)   1)
CA CHL/IU cells Min ( 0.1 mg/ml, +S9), 6-18h › 1)
1) Ministry of Health & Welfare, Japan: Tox. Test. Rep. of Environ. Chem., Vol. 5 (1997) (Tables in English)@
œ Acetaldehyde (ƒAƒZƒgƒAƒ‹ƒfƒqƒh) (Ethylaldehyde) @
@
75-07-0@@ Industry@@ 44.04
AM Sal Max ( 5.0 mg/plate, }S9); Max ( 1.0% vapor)   1, 12)
AM E.coli Min ( 0.039 mg/ml, -S9) › 2)
CA CHL/IU Min ( 0.02 mg/ml, -S9) › 3)
CA CHL/IU Min ( 0.02 mg/ml, -S9), 24h D20=0.025; TR=1300 › 13)
CA Hum. Ly Min ( 0.004 mg/ml, -S9) › 4)
SCE CH Min ( 0.004 mg/ml, -S9) › 5)
SCE Hum LY Min ( 0.004 mg/ml, -S9) › 6)
MN Rat/Skin Fb Min ( 0.022 mg/ml, -S9) › 7)
CT C3H 10T1/2 Min ( 0.1 mg/ml, -S9) › 8)
SLRL Drosophila Min ( 22,500 ppm, injection) › 9)
SCEv Mice Min ( 0.4 mg/kg) › 10)
MNv Mice Min ( 190 mg/kg x 1, ip), 24h › 11)
1) Mortelmans k, et al :Environ. Mol. Mutagen., 8 (Suppl. 7), 1-11(1986)@@@@@
2) Veghelyi PV, et al : Acta Pediatri. Acad. Sci. Hung., 19, 171-189 (1978)@
3) Ishidate M.Jr. (ed.)Data Book of Chromosomal Aberration Test In Vitro, LIC, Tokyo/Elsevier, Amsterdam (1988)
4) Obe G, et al.: Prog. Mutation Res., 5, 439-442 (1985)
5) Obe G & Beek B: Drug Alcohol Depend., 4, 91-94 (1979)
6) He S-M & Lambert BO: Mutation Res., 158, 201-208 (1985)
7) Bird RT, et al : Mutation Res., 101, 237-246 (1982)
8) Abernethy DJ, et al : Environ. Mol. Mutagen., 4, 331 (1982)
9) Woodruff RC, et al: Environ. Mutagen., 7, 677-702 (1985)
10) Obe G, et al: Mutation Res., 68, 291-294 (1979)
11) Morita T, et al: Mutation Res., 389, 3-122 (1997)
12) Ministry of Labour, Japan, Mutagen. Test Data of Exist. Chemi. Sub., JETOC(Ed.), pp. 171  (Tables in English)
13) Ministry of Labour, Japan, Mutagen. Test Data of Exist. Chemi. Sub., JETOC(Ed.), Suppl. 3, pp. 216 (2005) (Tables in English)

yReviewz@@@@@@@@@@@@@@@
1)IARC: Monograph, 36, pp.101-132 (1985)
2)IARC: Monograph, Carcinogen. Risks Human, 71 Pt2, 319-335 (1999)


US-NTP Genotoxicity ScreeningF
› Ames TestF@ 
› Drosophila (SLRL) test:
›
yNotez @(Sited from IARC Monog., Suppl. 6, 1987)
@No data were available on the genetic and related effects of acetaldehyde in humans. Acetaldehyde increased the incidence of SCEs in bone-marrow cells of mice and hamsters treated in vivo and induced CAs in rat embryos exposed in vivo. It induced DNA cross-links, CAs and SCEs in human cells in vitro and CAs, MNs and SCEs in cultured rodent cells. It induced MNs and SCEs in plants and DNA damage and mutation in bacteria. Acetaldehyde induced cross-links in isolated DNA. (IARC Monog., 36, 101, 1985).

œ Acetaminophen @
(Paracetamol; Hydroxyacetanilide) (ƒAƒZƒgƒAƒ~ƒmƒtƒFƒ“)@
@
103-90-2@ Medicine@ 151.17
AM Sal. Max (5.0 mg/plate, }S9)   1)
AM E.coli Max (30 ƒΚM, } -S9)   2)
CA CHL/IU Min ( 0.03 mg/ml, -S9), 48h, D20=0.023; TR=580 › 3)
CA CHO-K1 Min ( 0.07 mg/ml, -S9) › 4)
1) Jasiewicz ML & Richardson JC: Mutation Res., 190, 95-100 (1987)
2) King, M-T, et al : Mutation Res., 66, 33-43 (1978)
3) Sofuni T (Ed.):Data Book of Chromosomal Aberration Test In Vitro, LIC, Tokyo (1998)  (Tables in English)
4) Sasaki MS, et al : :Mutation Res., 122, 367-372 (1983)

yNotez
@@@@@@
   According to a review by Bergman, K., et al. iMutation Res., 349, 263-288 ,1996j, this agent was not mutagenic in bacteria or mammalian cells (except the MLA test), but was CHLastogenic both in vitro and in vivo systems at relatively high dose levels. Rannug U., et al. suggest that it causes a DNA-binding and induces chromosomal aberrations in peripheral lymphocytes even at a dose level of CHLinical use (Mutation Res., 327, 172-200, 1995). @@ Risk to human: IARC Monograph, 50, 307-332 (1990)

œ Acetanilide iƒAƒZƒgƒAƒjƒŠƒbƒhj(N-Phenylacetamide)@
@
103-84-4@@Industry@135.17

AM Sal Max ( 5.0 mg/plate, }S9)   1)
CA CHL/IU cells Max ( 1.6 mg/ml, -S9), 24h   2)
SCE Human Fb Max ( 1 x 10-2 M, -S9) ’ 3)
1) Wheeler LA ,et al: Proc. Natl. Acad. Sci. (USA), 72, 4607(1987)@@
2) Ishidate M.Jr and Odashima S: Mutation Res., 48, 337-354 (1977)
3) Wilmer JL, et al.: Environ. Mutagen., 3, 627-638 (1981)
@@@@@@@@@@@@@@@@@@@@@@@@@@@@@

œ Acetic acid, glacial
i|Ž_G•X|Ž_j
@
64-19-7@ Industry @60.0
AM Sal./ E.coli Max ( 1.0 mg/ml, }S9)   1)
CA CHL/IU Max ( 1.0 mg/ml, -S9), 24h   2)
SM Drosophila
(Eye-spot test)
Max (5%)   3)
MNv Mussel gill Min ( 0.5 M/L) › 4)
Other Chromo-test (SOS) Max (?)   5)
1) McCann J, et al: Proc Natl. Acad. Sci. (USA), 72, 3135-5139 (1975)
2) Ishidate M.Jr, et al: @Fd. Chem. Toxicol., 22, 623-636 (1984)@@@
3) Mollet P: Mutation Res., 40, 383-388 (1976)
4) Fumagalli O, et al: Mutation Res., 271, 183-184 (1992)
5) Hude W, et al,: Mutation Res., 203, 81-94 (1988) (a review)@@@@@@@@@@@@@@@@@@@@@@@

US-NTP Genotoxicity ScreeningF
›@Ames test:  

œ Acetoacetanilide
@ 102-01-2@ Industry @ 177.2
AM Sal./E.col. Min (0.078 mg/plate, +S9); spa= 1240 (E. coli) › 1)
CA CHL/IU Max ( 1.8 mg/ml, }S9), 6-18h   2)
1) Ministry of Labour, Japan, Mutagen. Test Data of Exist. Chemi. Sub., (Ed.) JETOC (Ed.), Suppl. 3, pp. 125 (2005)
 (Tables in English)
2) Ministry of Labour, Japan, Mutagen. Test Data of Exist. Chemi. Sub., (Ed.) JETOC (Ed.), Suppl. 3, pp. 236 (2005)
 (Tables in English)


œ Acetic anhydride@i–³…|Ž_j
@
108-24-7@ Industry @102.09
AM Sal./E.coli Max ( 2.5 mg/ml, }S9)   1)
1) Ministry of Labour, Japan, Mutagen. Test Data of Exist. Chemi. Sub., (Ed.) JETOC (Ed.), Suppl. (1997) (Tables in English)

œ o-Acetoacetotoluidine io-
ƒAƒZƒgƒAƒZƒgƒgƒ‹ƒCƒWƒ“j
@
93-68-5@ Industry@@ 191.23
AM Sal./E.col. Max ( 5.0 mg/plate, }S9)   1)
CA CHL/IU Max ( 2.5 mg/ml, -S9), 24h ’ 2)
1) Ministry of Health & Welfare, Japan: Tox. Test. Rep. of Environ. Chem., Vol. 7 (1999) (Tables in English)

œ p-Acetoacetotoluidine ip-ƒAƒZƒgƒAƒZƒgƒgƒ‹ƒCƒWƒ“j
@
2415-85-4@ Industry@@ 191.2
AM Sal. /E. col. Min ( 625 ƒΚg/plate, }S9); Spa=182 › 1)
1) Ministry of Labour, Japan, Mutagen. Test Data of Exist. Chemi. Sub., JETOC (Ed.), Suppl (1997) (in Japanese)@

œ Acetohexamide  (ƒAƒZƒgƒwƒLƒTƒ~ƒhj@
@
968-81-0@@Medicine@@324.42
AM Sal. / E. col Max ( 5.0 mg/plate, }S9)   1, 2)
CA CHL/IU Min ( 2.0 mg/ml, -S9), 24h, D20= 3.2; TR= 5.0 ›w 3)
SCEv CH/BM Max ( 3.3 x 10-3, po) ’ 4)
1) Dunkel VC et al: : Environ. Mutagen.(Suppl.5), 1-248 (1985)
2) Zeiger E. et al l: @Environ. Mol. Mutagen., 19 (Supple. 21), 2-141 (1992)@@
3) Sofuni T (Ed.): Data Book of Chromosome Aberration Test in vitro, LIC, Tokyo (1998) (Tables in English)
4) Renner HW & Munzner R: Mutation Res., 77, 349-355 (1980)

œ Acetone@
i
ƒAƒZƒgƒ“j
@
67-64-1@@Industry@@@58.08
@@@@@@@@@@@
AM Sal. Max ( 50.0 mg/plate, }S9)   1)
AM Sal/ E.coli Max ( 50 mg/plate, }S9)   2,3)
YM S.ponbe, P1 Max ( 5%, 1h, }S9)   4)
CA CHL/IU Max ( 40 mg/ml, -S9), 24h   5)
CA CHO Max ( 5.0 mg/ml, -S9), 2-10h   6)
CA Hum. Ly Max (?)   7)
SCE Hum LY Max (?)   7)
SCE CHO Max ( 5.0 mg/ml, }S9)   6)
SCE CHO Max (1% ),}S9)   8)
SCE Human Fb Max ( 8.6 x 10-5M, -S9)   9)
MLA L5178Y/TK@ Max ( 3.95 x 10-1, -S9   10)
SM/CT C3H 10T1/2 Max ( 0.5%)   11)
1) Ishidate M.Jr, et al: Food Chem. Toxicol., 22, 623-636(1975)
2) Flora SD, et al.: Mutation Res., 133, 161-198 (1984)@@@
3) McCann J, et al: Proc Natl. Acad. Sci. (USA), 72, 3135-5139 (1975)
4) Abbondandolo A, et al : Mutation Res., 79, 141-150 (1980)
5) Sofuni T (Ed.): Data Book of Chromosome Aberration Test
in vitro, LIC, Tokyo (1998)
6) Loveday KS, et al: Environ. Mol. Mutagen., 16, 272-303 (1990)
7) Norppa H: Carcinogenesis, 2, 237-242 (1981)@@@@@@@@@@@@@@@@
8) Tates AD & Kriek E: Mutation Res., 88, 397-410 (1981)
9) Sasaki M, et al: La Kromosomo II, 20,, 574-584 (1980)
10) Amacher D.E, et al: Mutation Res., 72, 447-474 (1980)
11) Patierno SR, et al: Cancer Res., 49, 1038-1044 (1992)@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@

yReviewz@
@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@
1) Kodolfo C, et al., Mutation Res., 171 (2), 179 (1992)@@@@@@@@@@@@@@@@@@@
@@@@@@@@@

œ Acetonitrile
@iƒAƒZƒgƒjƒgƒŠƒ‹;@ƒVƒAƒ“‰»ƒƒ`ƒ‹(Cyanomethane; Methanecarbonitrile)@
@
75-05-8@@Industry @ 41.05@@@
AM Sal. Max ( 10 mg/palate, }S9)   1)
SM CHO/HUPRT Max ( 30 mg/ml, }S9)   2)
CA CHO Max (?), }S9)   4)
CAv Drosophila Min (131 ppm, ih), Aneuploid › 4)
MNv Mice, BM/Lym. Max ( 125 mg/kg,ip) ’ 3)
1) EPA/OTS DOC.878220236 (1982)
2) EPA/OTS DOC.40-8446070 (1982)
3) Jones E., et al., Mutagenesis, 16, 151-154 (2001)
4) IPCS/WHO; Environ. Health Criteria, 154 (1993)

 US-NTP Genotoxicity ScreeningF@@@@@@@@@@@@@@@@@@@@@@@
›@Ames test: 
›@CA test:
’
›@SCE test:
›w

œ Acetophenone iƒAƒZƒgƒtƒFƒmƒ“j(Acetylbenzene) @
@
98-86-2@@ Industry @120.15

AM Sal. Max ( 5.0 mg/plate, }S9)   1,2)
CA CHL/IU Min ( 0.8 mg/ml, +S9), 6-18h, D20= 1.1; TR= 15 › 3)
1) Florin I, et al : Toxicology 15, 219-232 (1980)
2) Ministry of Labour,Japan,Mutagen. Test Data of Exist. Chemi. Subst., JETOC(Ed.j, Suppl. 2, (2000) (in Japanese)
3) Sofuni T (Ed.): Data Book of Chromosome Aberration Tests in vitro, LIC, Tokyo (1998)  (Tables in English)

œ N-Acetoxy-2-acetylaminofluoren (
N-ƒAƒZƒgƒLƒV-2-ƒAƒZƒ`ƒ‹ƒAƒ~ƒmƒtƒ[ƒŒƒ“j
@
 6098-44-8@Labouratory @281.31
AM Sal. Min ( 5 x 10-5M, }S9) › 1)
MB S. cerev. Min ( 50 mg/plate, }S9) › 2)
CA CH Min ( 0.5 ƒΚg/ml, -S9) › 3)
SCE CH Min ( 0.5 ƒΚg/ml, -S9) › 3)
CA Hum. Ly Min (?) › 4)
SCE Hum Fb Min ( 1ƒΚg/ml, -S9) › 5)
SM CH (8-AG) Min ( 0.1 nmoles-S9) › 6, 7)
UDS Hum Fb Min ( 1x 10-6M) › 8)
UDS Hum LY Min ( 0.001 mM) › 9)
CA BALB 3T3 Min ( 0.5 ƒΚg/ml) (Colony Assay) › 10)
SCEv Mice/BM Min ( 4.0 mg/kg, iv) › 11)
Other Chromo-test Min ( 0.1 nmoles-S9) › 12)
SCE CHO Min ( 10-4 mM, -S9) › 13)
MLA T5178Y/TK Min ( 0.70 x 10-6 , -S9) › 14)
1) Rosin MP & Stich HFl: Mutation Res., 54, 73 (1978)
2) Zimmermann FK.: Mutation Res., 11, 327-337 (1969)@@@
3) Popescu NC, et al.: J. Natl Cancr Inst., 59, 289-293 (1977)
4) Pero RW ,et al : Natl Acad. Sci.(USA), 73, 2496-2500(1976)
5) Schneider, EL and Gilman B: Humangenetik, 46, 57-63(1979)
6) Huberman E, et al.: J. Natl Cancr Inst., 48, 837-840 (1972)
7) Myhr BC & DiPaolo JA: Cancer Res., 38, 2539-2543 (1978)
8) San RH and Stich HF: Int. J. Cancer, 16, 284-291 (1975)
9) Martin CN, et al.: Cancer Res., 38, 2621-2627 (1978)
10)Dipaolo JA,
et al.: Cancer Res., 32, 2686-2695(1972)
11)Nakanishi Y & Schneider EL Mutation Res., 60, 329-337 (1979)
12)Quillardet P, et al,: Mutation Res., 147, 79-95 (1985)
13)Tates AD & Kriek E: Mutation Res., 88, 397-410 (1981)
14)Amacher DE, et al.: Mutation Res., 72, 447-
474 (1980)

œ Acetylacetone iƒAƒZƒ`ƒ‹ƒAƒZƒgƒ“j (2,4-Pentadione)@
@  
123-54-6 @Industry @100.11
AM Sal./E.coli Max ( 5.0 mg/plate, }S9)   1)
1) Ministry of Labour, Japan, Mutagen. Test Data of Exist. Chemi. Subst., JETOC (Ed..j (1996) (Tables in English)

œ p-Acetylaminobenzene sulfonylchloride
 (4-Acetylamino-benzensulfonyl chloride)
      121-60-8@Industry @233.68
AM Sal./E.coli Max ( 5.0 mg/plate, }S9)   1)
1) Ministry of Labour, Japan, Mutagen. Test Data of Exist. Chemi. Subst., JETOC (Ed.j (1996) (Tables in English)

œTop Page@iƒgƒbƒvƒy[ƒWj
œAbbreviation @iΘ—ͺ‹L†j@
œMutagenicity (•ΟˆΩŒ΄«j
œTest Systems@(ŽŽŒ±–@‚ΜŽν—ށj
œTechnical Problems@i‹Zp“I–β‘θ“_j
œList of@Compoundsi‰»‡•¨ƒŠƒXƒgj
œEvaluation of ResultsiŽŽŒ±Œ‹‰Κ‚Μ•]‰Ώj
œInformation i‚»‚Μ‘Ό‚̏ξ•ρj